These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30380355)

  • 1. Impact of Omega-3 Fatty Acids Among Other Nonpharmacological Interventions on Behavior and Quality of Life in Children with Compromised Conduct in Spain.
    Rodríguez-Hernández PJ; Canals-Baeza A; Santamaria-Orleans A; Cachadiña-Domenech F
    J Diet Suppl; 2020; 17(1):1-12. PubMed ID: 30380355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study.
    Huss M; Völp A; Stauss-Grabo M
    Lipids Health Dis; 2010 Sep; 9():105. PubMed ID: 20868469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
    Wu Q; Zhou T; Ma L; Yuan D; Peng Y
    Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder.
    Richardson AJ; Montgomery P
    Pediatrics; 2005 May; 115(5):1360-6. PubMed ID: 15867048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normative Data of the Self-Report Version of the German Strengths and Difficulties Questionnaire in an Epidemiological Setting.
    Becker A; Wang B; Kunze B; Otto C; Schlack R; Hölling H; Ravens-Sieberer U; Klasen F; Rogge J; Isensee C; Rothenberger A; Bella Study Group T
    Z Kinder Jugendpsychiatr Psychother; 2018 Nov; 46(6):523-533. PubMed ID: 29846123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled, crossover trial of fish oil treatment for impulsive aggression in children and adolescents with disruptive behavior disorders.
    Dean AJ; Bor W; Adam K; Bowling FG; Bellgrove MA
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):140-8. PubMed ID: 24689967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension.
    Manor I; Magen A; Keidar D; Rosen S; Tasker H; Cohen T; Richter Y; Zaaroor-Regev D; Manor Y; Weizman A
    Eur Psychiatry; 2012 Jul; 27(5):335-42. PubMed ID: 21807480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Towards a better assessment of child and adolescent mental health status. Polish version of strengths and difficulties questionnaire. Experiences from two population studies].
    Mazur J; Tabak I; Kololo H
    Med Wieku Rozwoj; 2007; 11(1):13-24. PubMed ID: 17965460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms.
    Cornu C; Mercier C; Ginhoux T; Masson S; Mouchet J; Nony P; Kassai B; Laudy V; Berquin P; Franc N; Le Heuzey MF; Desombre H; Revol O
    Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):377-384. PubMed ID: 28993963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.
    Johnson M; Ostlund S; Fransson G; Kadesjö B; Gillberg C
    J Atten Disord; 2009 Mar; 12(5):394-401. PubMed ID: 18448859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can ω-3 fatty acids and tocotrienol-rich vitamin E reduce symptoms of neurodevelopmental disorders?
    Gumpricht E; Rockway S
    Nutrition; 2014; 30(7-8):733-8. PubMed ID: 24631384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD).
    James S; Montgomery P; Williams K
    Cochrane Database Syst Rev; 2011 Nov; (11):CD007992. PubMed ID: 22071839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis.
    Cooper RE; Tye C; Kuntsi J; Vassos E; Asherson P
    J Affect Disord; 2016 Jan; 190():474-482. PubMed ID: 26551407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulsiveness in children with attention-deficit/hyperactivity disorder after an 8-week intervention with the Mediterranean diet and/or omega-3 fatty acids: a randomised clinical trial.
    San Mauro Martin I; Sanz Rojo S; González Cosano L; Conty de la Campa R; Garicano Vilar E; Blumenfeld Olivares JA
    Neurologia (Engl Ed); 2022 Sep; 37(7):513-523. PubMed ID: 34656505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acids in ADHD: plasma profiles in a placebo-controlled study of Omega 3/6 fatty acids in children and adolescents.
    Johnson M; Månsson JE; Ostlund S; Fransson G; Areskoug B; Hjalmarsson K; Landgren M; Kadesjö B; Gillberg C
    Atten Defic Hyperact Disord; 2012 Dec; 4(4):199-204. PubMed ID: 22753087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.